{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:01:58Z","timestamp":1774465318354,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T00:00:00Z","timestamp":1212969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background: <\/jats:bold> Cirrhosis is a diffuse process of hepatic fibrosis and regenerative nodule formation. The liver is the major source of circulating insulin\u2010like growth factor\u2010I (IGF\u2010I) whose plasma levels are diminished in cirrhosis. IGF\u2010I supplementation has been shown to induce beneficial effects in cirrhosis, including antifibrogenic and hepatoprotective effects. On other hand, interferon\u2010\u03b1 (IFN\u2010\u03b1) therapy seems to suppress the progression of hepatic fibrosis.<\/jats:p><jats:p><jats:bold>Aims: <\/jats:bold> The aim of this study was to investigate the effect of the co\u2010administration of IGF\u2010I+IFN\u2010\u03b1 to <jats:italic>Wistar<\/jats:italic> rats with CCl<jats:sub>4<\/jats:sub>\u2010induced cirrhosis, exploring liver function tests, hepatic lipid peroxidation and histopathology.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> The mechanisms underlying the effects of these agents were studied by reverse transcription\u2010polymerase chain reaction, determining the expression of some factors [hepatocyte growth factor (HGF), transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2), \u03b1\u2010smooth muscle actin, collagen, tissular inhibitor of metalloproteinases\u20101 and pregnane X receptor (PXR)] involved in fibrogenesis, fibrolysis and\/or hepatoprotection.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Both IGF\u2010I and IFN\u2010\u03b1 exerted significant effects on fibrogenesis. IGF\u2010I significantly increased serum albumin and HGF whereas IFN\u2010\u03b1\u2010therapy did not. The inhibition of TGF\u2010\u03b2 expression was only observed by the effect of IFN\u2010\u03b1\u2010therapy. In addition, only the co\u2010administration of IGF\u2010I and IFN\u2010\u03b1 was able to increase the PXR. The combined therapy with both factors improved liver function tests, hepatic lipid peroxidation and reduced fibrosis, inducing a relevant histological improvement, reducing fibrosis and recovering hepatic architecture.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> The co\u2010administration IGF\u2010I+IFN enhanced all the beneficial effects observed with each factor separately, showing an additive action on histopathology and PXR expression, which is involved in the inhibition of fibrogenesis.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01770.x","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T09:41:33Z","timestamp":1269942093000},"page":"37-46","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced actions of insulin\u2010like growth factor\u2010I and interferon\u2010\u03b1 co\u2010administration in experimental cirrhosis"],"prefix":"10.1111","volume":"29","author":[{"given":"Federico","family":"Tutau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rodr\u00edguez\u2010Ortigosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Enrique","family":"Puche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Juanarena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1igo","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarna","family":"Clavijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inma","family":"Castilla \u2010 Cort\u00e1zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,12]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"359","article-title":"Reduced serum somatomedin activity in patients with chronic liver disease","volume":"47","author":"Wu A","year":"1974","journal-title":"Clin Sci Mol Med"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80026-8"},{"key":"e_1_2_7_4_2","first-page":"319","article-title":"Altered intestinal transport of amino acids in cirrhotic rats","volume":"279","author":"Pascual M","year":"2000","journal-title":"the effect of insulin-like growth factor-I"},{"key":"e_1_2_7_5_2","first-page":"37","article-title":"In vivo study of intestinal absorption of d\u2010Galactose in cirrhotic rats","volume":"276","author":"Castilla\u2010Cort\u00e1zar I","year":"1999","journal-title":"effect of insulin-like growth factor I"},{"key":"e_1_2_7_6_2","first-page":"1180","article-title":"Impaired intestinal sugar transport in cirrhotic rats","volume":"113","author":"Castilla\u2010Cort\u00e1zar I","year":"1997","journal-title":"correction by low doses of insulin-like growth factor I"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310308"},{"key":"e_1_2_7_8_2","first-page":"2529","article-title":"Hematotesticular barrier is altered from early stages of liver cirrhosis","volume":"10","author":"Castilla\u2010Cortazar I","year":"2004","journal-title":"effect of insulin-like growth factor 1"},{"key":"e_1_2_7_9_2","first-page":"215","article-title":"Insulin\u2010like growth factor\u2010I restores the reduced somatostatinergic tone controlling GH secretion in cirrhotic rats","volume":"37","author":"Castilla\u2010Cort\u00e1zar I","year":"2001","journal-title":"Liver"},{"key":"e_1_2_7_10_2","first-page":"122","article-title":"Osteopenia in rats with liver cirrhosis","volume":"28","author":"Cemborain A","year":"1998","journal-title":"beneficial effects of IGF-I-treatment"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352873"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(01)00123-6"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(01)00045-X"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-5-7"},{"key":"e_1_2_7_15_2","first-page":"630","article-title":"Insulin\u2010like growth factor I (IGF\u2010I) replacement therapy increases albumin concentration in liver cirrhosis","volume":"43","author":"Conchillo M","year":"2005","journal-title":"results of a pilot randomized controlled clinical trial"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70135-6"},{"key":"e_1_2_7_17_2","first-page":"1","article-title":"Reduced plasma transforming growth factor\u2010beta 1 levels in patients with chronic hepatitis C after interferon alpha therapy","volume":"30","author":"Tsushima H","year":"1999","journal-title":"association with regression of hepatic fibrosis"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104043241401"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80148-6"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80230-5"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i17.2634"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80012-3"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3703"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.012"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2002.01731.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700116"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240207"},{"key":"e_1_2_7_29_2","first-page":"836","article-title":"Liver regeneration","volume":"5","author":"Taub R.","year":"2004","journal-title":"from myth to mechanism"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(87)90624-3"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.9109"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01770.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01770.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:58:44Z","timestamp":1697115524000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01770.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01770.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01770.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,12]]}}}